ArticleCell communication and signaling : CCS2020

Repositioning liothyronine for cancer immunotherapy by blocking the interaction of immune checkpoint TIGIT/PVR.

Xiuman Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.